Systolic blood pressure and albuminuria reduction mediate cardiovascular benefits of finerenone in T2 diabetes and CKD

Rajiv Agarwal, Ambarish Pandey, Scott D Solomon, Muthiah Vaduganathan, Faiez Zannad

DOI: 10.1093/ndt/gfag150
Published: 2026-06-26
Container: Nephrology Dialysis Transplantation
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ndt/gfag150,
  title = {Systolic blood pressure and albuminuria reduction mediate cardiovascular benefits of finerenone in T2 diabetes and CKD},
  author = {Rajiv Agarwal and Ambarish Pandey and Scott D Solomon and Muthiah Vaduganathan and Faiez Zannad},
  year = {2026},
  journal = {Nephrology Dialysis Transplantation},
  doi = {10.1093/ndt/gfag150},
  url = {https://doi.org/10.1093/ndt/gfag150}
}

RIS

TY  - JOUR
TI  - Systolic blood pressure and albuminuria reduction mediate cardiovascular benefits of finerenone in T2 diabetes and CKD
AU  - Rajiv Agarwal
AU  - Ambarish Pandey
AU  - Scott D Solomon
AU  - Muthiah Vaduganathan
AU  - Faiez Zannad
PY  - 2026
JO  - Nephrology Dialysis Transplantation
DO  - 10.1093/ndt/gfag150
UR  - https://doi.org/10.1093/ndt/gfag150
ER  -

APA

Agarwal, R., Pandey, A., Solomon, S. D., Vaduganathan, M., & Zannad, F. (2026). Systolic blood pressure and albuminuria reduction mediate cardiovascular benefits of finerenone in T2 diabetes and CKD. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfag150

Source records

hal · retrieved 2026-09-27T04:54:23.602Z